Arno Thaller provides investigational oncolytic virus (OV) treatment for eligible patients. OVs preferentially replicate within cancer cells and induce their death, while sparing healthy cells. They also infect tumor-associated endothelial cells, leading to breakdown of tumor vasculature and subsequent necrosis of uninfected tumor cells. In cancer cells, OVs rely on signaling pathways to establish infection and exploit defective anti-viral immune responsiveness to evade immune surveillance. The definition of “onco-lysis” is tumor destruction.
OV with cancer immunotherapy is a combined therapeutic approach. The administered oncolytic virus (OV) attacks the cancer cells, leaving normal human cells untouched. As a result this treatment has no significant side effects. Furthermore, OV combined with other therapies is a promising approach with potential to extend survival time and even cure, while quality of life is maintained.
Arno Thaller, Physician
Arno Thaller is a physician with a clinic, Praxisklinik Arno Thaller, located in Markt Berolzheim, Bavaria, Germany. He has long-standing clinical experience and expertise in oncology. He pioneered innovative therapeutic regiments for end-stage cancer patients and untreatable tumors. Based on the German regulation for innovative treatment for end-stage cancer patients, he combines the use of OV with new immunotherapeutic agents.
Approbation as a doctor: 1980 Sweden
Approval as a general practitioner by Bayerische Landesärztekammer in 1994
Recognition of additional qualification in naturopathy in 1994 by Bayerische Landesärztekammer
Bayerische LandesärztekammerMühlbaurstr. 16
Link to the Rules of Professional Practice:
MFA, HP, Nurse